Scripps research scientist wins 2004 Koch Prize

Professor Bruce Beutler, M.D., of The Scripps Research Institute has won the 2004 Robert Koch Award together with Professor Shizuo Akira of Osaka, Japan and Professor Jules A. Hoffmann of Strasbourg, France, the Robert Koch Foundation has announced.

"I'm completely thrilled," says Beutler, Scripps Research professor of immunology. "I have never won such a prestigious award before, and I am honored to be included with two people who are so completely deserving [as Akira and Hoffmann]."

The prize is one the highest scientific honors of the Federal Republic of Germany. It is given annually under the patronage of the Federal Minister of Health to researchers for outstanding, internationally recognized scientific achievements.

It is named in honor of Robert Koch, one of the founding fathers of immunology. Koch developed microbiological techniques that have been in use for more than 100 years. He was the first person to isolate the cholera vibrio and the anthrax bacillus, and he won the 1905 Nobel Prize in Physiology or Medicine for his discovery and subsequent investigations of the tuberculosis bacillus.

In winning the Robert Koch Award, Beutler was acknowledged by the foundation for his "groundbreaking research on molecular mechanisms underlying recognition, signal transduction, and effector functions" of the immune system. He uses a technique called forward genetics to study human genes used by the innate immune system to clear pathogens from the body.

"Innate immunity plays a key role in many human diseases," says Professor Richard Ulevitch, who is the chair of the Department of Immunology at Scripps Research. "Beutler's use of forward genetics to understand innate immunity will produce novel insights into the physiological pathways and mechanisms of innate immunity as it relates to human disease."

Last year, Beutler and his Scripps Research colleague Dr. Kasper Hoebe identified a protein called

Contact: Jason Bardi
Scripps Research Institute

Page: 1 2

Related biology news :

1. Structure solved at Scripps shows how one human protein reduces potency of chemotherapy
2. Protein believed to control formation of memory identified by Scripps & UCSD scientists
3. 22-amino acid bacterium created by Scripps scientists
4. Scripps scientists look deep inside sharks and their high-performance swimming system
5. Scripps Research scientists find deafness genes function
6. New approach limits damage after heart attack and improves survival, say Scripps Research scientists
7. Scripps scientists describe dangerous cocktail of alcohol, brain peptides, and neurotransmitters
8. Chemical that turns mouse stem cells into heart muscles discovered by Scripps researchers
9. Structure solved by Scripps scientists shows one way that body controls gene expression
10. Scripps scientists say genetic mutation doesnt protect against HIV and plague
11. Scientists at Scripps Research Institute describe structure of receptor on surface of 1918 flu virus

Post Your Comments:

(Date:7/22/2020)... ... July 21, 2020 , ... ... and innovation in technology and compliance, announces a new solution to manage regulated ... ensure every layer of their technology stack complies with FDA and global regulations. ...
(Date:7/10/2020)... ... 09, 2020 , ... Today CJ BIO announced the first in a series ... “fifth taste” phenomenon that is revolutionizing ingredient mixes, nutritional content and flavor profiles across ... Monday, July 13, 2020 at11:00 AM (CDT) during SHIFT20, the virtual edition of the ...
(Date:7/1/2020)... N.J. (PRWEB) , ... July 01, 2020 , ... ... announced that it had completed the purchase of Teva-Takeda Pharmaceuticals’ packaging facility in ... the company’s existing Japanese clinical supply facility located in Kakegawa, the new 60,000-square-foot ...
Breaking Biology News(10 mins):
(Date:8/31/2020)... , ... August 29, 2020 , ... ... Animal Nutrition manufacturing capability in Wuxi, China. The new plant operation will provide ... standards and advanced technology. , “This facility will improve the flexibility of ...
(Date:8/12/2020)... Mass. (PRWEB) , ... August 11, 2020 , ... ... $300,000 a year to expand the Facioscapulohumeral Muscular Dystrophy Clinical Trial Research ... in 2021 and 2022. The network is a consortium of academic research centers ...
(Date:8/7/2020)... ... August 06, 2020 , ... ... industries, announces it has closed on the purchase of greenfield for a new, ... TX and includes over 21 acres in the initial acquisition, with an option ...
(Date:7/31/2020)... ... July 29, 2020 , ... R3 Stem Cell International is now offering patients ... million stem cells total, patients may choose which extremities they would like treated. , ... (BMC Musculoskelet Disord. 2016). At R3 International, umbilical cord tissue is obtained from a ...
Breaking Biology Technology:
Cached News: